Janssen Korea to launch new protease inhibitor

Janssen Korea says it will launch its new protease inhibitor Prezista (darunavir) sooner or later after being placed on the list of health insurance guaranteed products.

Prezista, which was approved by the U.S. Food and Drug Administration in July 2006, is active against many of the viruses resistant to other protease inhibitors for the treatment of human immunodeficiency virus (HIV) infecti...